Reven Pharmaceuticals Stock
Reven Pharmaceuticals is a startup developing solutions for the treatment of cardiovascular and circulatory-related conditions.
About Reven Pharmaceuticals Stock
Reven Pharmaceuticals, Inc. is a development-stage bio-pharmaceutical company that develops and markets propriety solutions for the treatment of cardiovascular and circulatory related conditions. These non-surgical, minimally invasive treatments have shown to improve vascular function and circulation without invasive medical procedures, such as atherectomy or balloon angioplasty and stents.
Funding History
| January 2014 | $1.8M |
|---|---|
| February 2015 | $4.4M |
Management
Vice President, Regulatory and Quality Affairs
Brian Denomme
Co-Founder and Chief Executive Officer
Michael K. Handley
Vice President of Operations
Mariëtte Luïse Van Wyk
President
Peter Lange
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Reven Pharmaceuticals or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
